Externalize costs without breaking the data value chain

Externalizing discovery screening processes can help with focusing on adding value in-house but it's important to preserve the efficiency and integrity of your data value chain

Join Andy Vines of IDBS and Justin Gazard of Pfizer Inc. as they explore successful approaches to externalization in the drug discovery space, covering:

  • Approaching externalization – understanding your options
  • Making externalization a reality – getting the infrastructure right
  • Successful externalization – don’t compromise on the efficiency of your data value chain
  • Externalize costs, internalize value – achieving results that matter

Presented by:

  • Andy Vines, Product Manager, Screening Solutions, IDBS
  • Justin Gazard, Pharmacology Data Manager, Pfizer Inc.